Stay tuned for details about the opening of the 2024 program application
The Flinn Foundation Bioscience Entrepreneurship Program provides $30,000 in non-dilutive funding plus support and connections.
The application typically opens in September for the following year’s program. A timeline of key dates will be released during the summer.
In addition to the application, a two-page business plan, pitch deck, and one letter of recommendation is required to be considered for participation in the program. The business plan must address the company’s business model, financing, execution, market and its product or service.
After interviews in February with industry and scientific experts chosen by the Flinn Foundation, up to six firms are competitively selected for the program.
To be eligible for the program, an entity must be an Arizona-based bioscience firm engaged in the commercialization of bioscience research and biotechnology and/or the sale of products in the areas of:
- Medical devices and equipment;
- Drugs, pharmaceuticals and diagnostics;
- Agricultural feedstock and chemicals;
- Research, testing and medical labs;
- Bioscience-related distribution.
The firm must be incorporated as an S-Corp, LLC, or C-Corp, and based in Arizona and in pre- or early-revenue stage. Research-only projects do not qualify.
On the rise in 2023: Six Arizona bioscience startups
Program benefits and background
Meet the program participants from 2014 to today
For more information about the program, contact Mary O’Reilly, Ph.D., Flinn Foundation Vice President, Bioscience Research Programs at firstname.lastname@example.org or 602-744-6837.
Diversity drives innovation. While diversity is often used in reference to race, ethnicity, and gender, we understand it to also include diversity in one’s background, life experiences, skill set, and self-identification. We encourage all to apply.